维普中文期刊产品整合服务
34篇 您的检索式:作者名="GANESAMONI R"
    题名 作者 年代 出处 被引量
1Risk factors for urosepsis following percutaneous nephrolithotomy:role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 2011Urol Res2011,13,5:1
2Mieroper- cutaneous nephrolithotomy (microperc) vs retrograde intrarenal surgery for the management of small renal calculi: a randomized controlled trial显示文摘SABNIS R B GANESAMONI R DOSHI A 2013BJU Int2013,112,3:1
3Efficacy of holmium laser urethrotomy in combination with intrale- sional triamcinolone in the treatment of anterior ure- thral stricture显示文摘Kumar S Kapoor A Ganesamoni R 2012KoreanJ Urol2012,53,9:1
4Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitro- furantoin in reducing the risk of urosepsis 显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,:1
5Supine percutaneous nephrolithotomy for bilateral complete staghorn calculi in an L-shaped cross-fused renal ectopic anomaly显示文摘Mishra S Ganesamoni R Ganpule AP 2013Urology2013,,01:1
6Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 2012UrolRes2012,40,1:1
7U rethral steinstrasse with urethrocutaneous fistula显示文摘Kumar S Sharma S Ganesamoni R 2012Urology2012,79,2:1
8Risk factors for urosepsisfollowing percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,1:1
9Risk factors for urosepsis following percutaneous nephrolithotomy:role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 0,,:1
10Micropereutaneous nephrolithotomy (microperc) vs retrograde intrarenal surgery for the management of small renal calculi: a randomized controlled trial显示文摘Sabnis RB Ganesamoni R Doshi A 2013BJU lnt2013,112,:1
11Risk factors for urosepsis following percutaneous nephro- lithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘KUMAR S  BAG S GANESAMONI R 2012Urol Res2012,40,1:1
12Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones显示文摘Kumar S Kurdia KC Ganesamoni R 2013Korean J Urol2013,54,5:1
13Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones 显示文摘Kumar S Kurdia K C Ganesamoni R 2013Korean J Urol2013,54,5:1
14Micropercutane ous nephrolithotomy (microperc) vs retrograde intrarenal sur- gery for the management of small renal calculi: a randomized controlled trial显示文摘Sabnis R B Ganesamoni R Doshi A 2013BJU Int2013,112,3:1
15Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis 显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,1:1
16Eosinophilic cystitis mimicking tuberculosis: an analysis of five cases with review of literature显示文摘Kumar S Sharma V Ganesamoni R 2013Urol Ann2013,5,1:1
17Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,1:1
18Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitro- furantoin in reducing the risk of urosepsis 显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,1:1
19Risk factors for urosepsis following percutaneous nephrolithotomy:role of 1 week of nitrofurantoin in reducing the risk of urosepsis显示文摘Kumar S Bag S Ganesamoni R 2012Urol Res2012,40,1:1
20Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones显示文摘KUMAR S KURDIA KC GANESAMONI R 2013Korean J Urol2013,54,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费